Home/Filings/4/0001628280-22-005795
4//SEC Filing

Ruffner Katherine L 4

Accession 0001628280-22-005795

CIK 0001213037other

Filed

Mar 9, 7:00 PM ET

Accepted

Mar 10, 6:42 PM ET

Size

5.5 KB

Accession

0001628280-22-005795

Insider Transaction Report

Form 4
Period: 2022-03-09
Ruffner Katherine L
Chief Medical Officer
Transactions
  • Award

    Stock Options

    2022-03-09+170,016370,016 total
    Exercise: $2.50Exp: 2032-03-09Common Stock (170,016 underlying)
Footnotes (1)
  • [F1]42,504 vest on 3/09/2023. 3,542 vest monthly for 36 months beginning on 4/09/2023 through 3/09/2026.

Issuer

Cardiff Oncology, Inc.

CIK 0001213037

Entity typeother

Related Parties

1
  • filerCIK 0001872306

Filing Metadata

Form type
4
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 6:42 PM ET
Size
5.5 KB